Evry, France - November 27, 2017 (Investorideas.com Newswire) ATA Insights' comprehensive program focuses on the commercially relevant topics to renewable energy professionals today, both in terms of technical perspectives and understanding markets and how they work. This month, the program offers three industry expert lead webinars:
Using proven technologies, Global Bioenergies condensed isobutene molecules to produce a cosmetic ingredient used in numerous formulations for its texturing properties. The ingredient is one of the six main components used in cosmetics.
Global Bioenergies' innovation produces the ingredient based on plants as an alternative to the fossil resources used in the industry today. Our bio-isobutene was first converted by the Fraunhofer Institute in Germany and then purified before delivery to L'Oréal. This is a test batch. L'Oréal will use the new ingredient in its cosmetic formulations and check that the results meet their specifications.
Marc Delcourt, CEO of Global Bioenergies, said: "Delivery of this batch of renewable ingredient is a major step forward in the ISOPROD project. It will be followed by other batches, produced as part of both ISOPROD and another European programme in partnership with two leading specialty chemical companies, CLARIANT and INEOS. L'Oréal is the leading cosmetics firm to promote leaving fossil resources out of its formulas. The transition to sustainable chemicals and materials is accelerating as a growing number of major companies similarly drive the change towards a greener future."
About GLOBAL BIOENERGIES
Global Bioenergies is one of the few companies worldwide, and the only one in Europe, that is developing a process to convert renewable resources into hydrocarbons through fermentation. The Company initially focused its efforts on the production of isobutene, one of the most important petrochemical building blocks that can be converted into fuels, plastics, organic glass and elastomers. Global Bioenergies continues to improve the performances of its process, operates its demo plant in Germany, and prepares the first full-scale plant through a Joint-Venture with Cristal Union, named IBN-One. Global Bioenergies is listed on Euronext Growth Paris (FR0011052257 - ALGBE).
Should you like to be kept informed, subscribe to our news feed on www.global-bioenergies.com
Follow us on Twitter: @GlobalBioenergi
Head of Business Development
Phone: +33 1 64 98 20 50
This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.